대표어
한국학술지인용색인(NRF)
권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
국회도서관 홈으로
정보검색
소장정보 검색
결과 내 검색
동의어 포함
-
-
권호기사
참고문헌 (304건) : 자료제공( 네이버학술정보 )
| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | Zhou X, Ni Y, Liang X, Lin Y, An B, He X, Zhao X. Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance. Front Immunol. 2022;13:Article 915094. | 미소장 |
| 2 | Yu X, Fang C, Zhang K, Su C. Recent advances in nanoparticles-based platforms targeting the PD-1/PD-L1 pathway for cancer treatment. Pharmaceutics. 2022;14(8):1581. | 미소장 |
| 3 | Liu X, Yuan Z, Tang Z, Chen Q, Huang J, He L, Chen T. Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics. Biomater Sci. 2021;9(13):4691–4700. | 미소장 |
| 4 | Liu Y, Pan Y, Cao W, Xia F, Liu B, Niu J, Alfranca G, Sun X, Ma L, de la Fuente JM, et al. A tumor microenvironment responsive biodegradable CaCO3/MnO2- based nanoplatform for the enhanced photodynamic therapy and improved PD-L1immunotherapy. Theranostics. 2019;9(23):6867–6884. | 미소장 |
| 5 | Zhang J, Fan B, Cao G, Huang W, Jia F, Nie G, Wang H. Direct presentation of tumor-associated antigens to induce adaptive immunity by personalized dendritic cell-mimicking nanovaccines. Adv Mater. 2022;34(47):2205950. | 미소장 |
| 6 | He A, Li X, Dai Z, Li Q, Zhang Y, Ding M, Wen Z, Mou Y, Dong H. Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy. J Nanobiotechnology. 2023;21(1):236. | 미소장 |
| 7 | Hu Y, Paris S, Bertolet G, Barsoumian HB, Wang Q, Da Silva J, Patel NB, Nguyen N, Doss DJ, Huang A, et al. NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1resistant lung cancer model. Front Immunol. 2022;13:1022011. | 미소장 |
| 8 | Esmaily M, Masjedi A, Hallaj S, Nabi Afjadi M, Malakotikhah F, Ghani S, Ahmadi A, Sojoodi M, Hassannia H, Atyabi F, et al. Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine. J Control Release. 2020;326:63–74. | 미소장 |
| 9 | Feng Y, Xie X, Zhang H, Su Q, Yang G, Wei X, Li N, Li T, Qin X, Li S, et al. Multistage-responsive nanovehicle to improve tumor penetration for dual-modality imagingguided photodynamic-immunotherapy. Biomaterials. 2021;275:Article 120990. | 미소장 |
| 10 | Wang Y, Wang H. Lymph node targeting for immunotherapy. Immunooncol Technol. 2023;20:Article 100395. | 미소장 |
| 11 | Morisaki T, Morisaki T, Kubo M, Morisaki S, Nakamura Y, Onishi H. Lymph nodes as anti-tumor immunotherapeutic tools: Intranodal-tumor-specific antigen-pulsed dendritic cell vaccine immunotherapy. Cancers. 2022;14(10):2438. | 미소장 |
| 12 | Liu F, Tan L, Dai Z, Wang Y, Huang L, Zhang Y, Cheng Q, Li X, Liu M-D, Wang L, et al. Manganese-based microcrystals equipped with Ythdf1-targeted biomimetic nanovaccines for reinforced dendritic cell spatiotemporal orchestration. Nano Today. 2024;54:Article 102112. | 미소장 |
| 13 | Zou Z, Lin H, Li M, Lin B. Tumor-associated macrophage polarization in the inflammatory tumor microenvironment. Front Oncol. 2023;13:1103149. | 미소장 |
| 14 | Meir R, Shamalov K, Betzer O, Motiei M, Horovitz-Fried M, Yehuda R, Popovtzer A, Popovtzer R, Cohen CJ. Nanomedicine for cancer immunotherapy: Tracking cancerspecific T-cells in vivo with gold nanoparticles and CT imaging. ACS Nano. 2015;9(6):6363–6372. | 미소장 |
| 15 | Cevaal PM, Ali A, Czuba-Wojnilowicz E, Symons J, Lewin SR, Cortez-Jugo C, Caruso F. In vivo T cell-targeting nanoparticle drug delivery systems: Considerations for rational design. ACS Nano. 2021;15(3):3736–3753. | 미소장 |
| 16 | Huang L, Ge X, Liu Y, Li H, Zhang Z. The role of toll-like receptor agonists and their nanomedicines for tumor immunotherapy. Pharmaceutics. 2022;14(6):1228. | 미소장 |
| 17 | Siegler EL, Kim YJ, Wang P. Nanomedicine targeting the tumor microenvironment: Therapeutic strategies to inhibit angiogenesis, remodel matrix, and modulate immune responses. J Cell Immunotherapy. 2016;2(2):69–78. | 미소장 |
| 18 | Song H, Sun H, He N, Xu C, Wang Y, Du L, Liu Y, Wang Q, Ji K, Wang J, et al. Gadolinium-based ultra-small nanoparticles augment radiotherapy-induced T-cell response to synergize with checkpoint blockade immunotherapy. Nanoscale. 2022;14(31):11429–11442. | 미소장 |
| 19 | Zhang L, Xu L, Wang Y, Liu J, Tan G, Huang F, He N, Lu Z. A novel therapeutic vaccine based on graphene oxide nanocomposite for tumor immunotherapy. Chin Chem Lett. 2022;33:4089–4095. | 미소장 |
| 20 | Almeida JPM, Lin AY, Figueroa ER, Foster AE, Drezek RA. In vivo gold nanoparticle delivery of peptide vaccine induces anti-tumor immune response in prophylactic and therapeutic tumor models. Small. 2015;11(12):1453–1459. | 미소장 |
| 21 | Almeida JPM, Figueroa ER, Drezek RA. Gold nanoparticle mediated cancer immunotherapy. Nanomedicine. 2014;10(3):503–514. | 미소장 |
| 22 | An J, Liu M, Zhao L, Lu W, Wu S, Zhang K, Liu J, Zhang Z, Shi J. Boosting tumor immunotherapy by bioactive nanoparticles via Ca2+ interference mediated TME reprogramming and specific PD-L1 depletion. Adv Funct Mater. 2022;32(24):2201275. | 미소장 |
| 23 | Qi J, Jin F, You Y, Du Y, Liu D, Xu X, Wang J, Zhu L, Chen M, Shu G, et al. Synergistic effect of tumor chemoimmunotherapy induced by leukocyte-hitchhiking thermalsensitive micelles. Nat Commun. 2021;12(1):4755. | 미소장 |
| 24 | Pham LM, Poudel K, Ou W, Phung CD, Nguyen HT, Nguyen BL, Karmacharya P, Pandit M, Chang J-H, Jeong J-H, et al. Combination chemotherapeutic and immune-therapeutic anticancer approach via anti-PD-L1antibody conjugated albumin nanoparticles. Int J Pharm. 2021;605:Article 120816. | 미소장 |
| 25 | Zhao Y, Liu X, Liu X, Yu J, Bai X, Wu X, Guo X, Liu Z, Liu X. Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer. Front Immunol. 2022;13:Article 955920. | 미소장 |
| 26 | Zeng W, Li Z, Chen H, Zeng X, Mei L. An optimal portfolio of photothermal combined immunotherapy. Cell Rep Phys Sci. 2022;3(6):Article 100898. | 미소장 |
| 27 | Wang C, Wu L, Yuan H, Yu H, Xu J, Chen S, Yan S, Wang X. A powerful antitumor “trident”: The combination of radio-, immuno- and anti-angiogenesis therapy based on mesoporous silica single coated gold nanoparticles. J Mater Chem B. 2023;11(4):879–889. | 미소장 |
| 28 | Sumbayev VV, Yasinska IM, Garcia CP, Gilliland D, Lall GS, Gibbs BF, Bonsall DR, Varani L, Rossi F, Calzolai L. Gold nanoparticles downregulate interleukin-1β-induced proinflammatory responses. Small. 2013;9(3):472–477. | 미소장 |
| 29 | Tsai C-Y, Lu S-L, Hu C-W, Yeh C-S, Lee G-B, Lei H-Y. Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages. J Immunol. 2012;188(1):68–76. | 미소장 |
| 30 | Moyano DF, Goldsmith M, Solfiell DJ, Landesman-Milo D, Miranda OR, Peer D, Rotello VM. Nanoparticle hydrophobicity dictates immune response. J Am Chem Soc. 2012;134(9):3965–3967. | 미소장 |
| 31 | Niikura K, Matsunaga T, Suzuki T, Kobayashi S, Yamaguchi H, Orba Y, Kawaguchi A, Hasegawa H, Kajino K, Ninomiya T, et al. Gold nanoparticles as a vaccine platform:Influence of size and shape on immunological responses in vitro and in vivo. ACS Nano. 2013;7(5):3926–3938. | 미소장 |
| 32 | Liu Q, Zhou Y, Li M, Zhao L, Ren J, Li D, Tan Z, Wang K, Li H, Hussain M, et al. Polyethylenimine hybrid thin-shell hollow mesoporous silica nanoparticles as vaccine selfadjuvants for cancer immunotherapy. ACS Appl Mater Interfaces. 2019;11(51):47798–47809. | 미소장 |
| 33 | Bai S, Jiang H, Song Y, Zhu Y, Qin M, He C, Du G, Sun X. Aluminum nanoparticles deliver a dual-epitope peptide for enhanced anti-tumor immunotherapy. J Control Release. 2022;344:134–146. | 미소장 |
| 34 | Wu Y, Gu W, Li J, Chen C, Xu ZP. Silencing PD-1 and PD-L1with nanoparticle-delivered small interfering RNA increases cytotoxicity of tumor-infiltrating lymphocytes. Nanomedicine. 2019;14(8):955–967. | 미소장 |
| 35 | Feng Y, Wu J, Chen J, Lin L, Zhang S, Yang Z, Sun P, Li Y, Tian H, Chen X. Targeting dual gene delivery nanoparticles overcomes immune checkpoint blockade induced adaptive resistance and regulates tumor microenvironment for improved tumor immunotherapy. Nano Today. 2021;38:Article 101194. | 미소장 |
| 36 | Neek M, Tucker JA, Butkovich N, Nelson EL, Wang S-W. An antigen-delivery protein nanoparticle combined with anti-PD-1 checkpoint inhibitor has curative efficacy in an aggressive melanoma model. Adv Ther. 2020;3(12):2000122. | 미소장 |
| 37 | Moon Y, Shim MK, Choi J, Yang S, Kim J, Yun WS, Cho H, Park JY, Kim Y, Seong J-K, et al. Anti-PD-L1peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death. Theranostics. 2022;12(5):1999–2014. | 미소장 |
| 38 | Zhang P, Chiu Y-C, Tostanoski LH, Jewell CM. Polyelectrolyte multilayers assembled entirely from immune signals on gold nanoparticle templates promote antigen-specific T cell response. ACS Nano. 2015;9(6):6465–6477. | 미소장 |
| 39 | Jiang C, Zhang L, Xu X, Qi M, Zhang J, He S, Tian Q, Song S. Engineering a smart agent for enhanced immunotherapy effect by simultaneously blocking PD-L1 and CTLA-4. Adv Sci. 2021;8(20):2102500. | 미소장 |
| 40 | Zhang J, Liu D, Liu J, Han Y, Xu H, Leng X, Kong D, Liu L. Hybrid spherical nucleotide nanoparticles can enhance the synergistic anti-tumor effect of CTLA-4 and PD-1 blockades. Biomater Sci. 2020;8(17):4757–4766. | 미소장 |
| 41 | Möller K, Bein T. Degradable drug carriers: Vanishing mesoporous silica nanoparticles. Chem Mater. 2019;31(12):4364–4378. | 미소장 |
| 42 | Park J, Choi SW, Cha BG, Kim J, Kang S-J. Alternative activation of macrophages through interleukin-13-loaded extra-large-pore mesoporous silica nanoparticles suppresses experimental autoimmune encephalomyelitis. ACS Biomater Sci Eng. 2021;7(9):4446–4453. | 미소장 |
| 43 | Bavnhøj CG, Knopp MM, Madsen CM, Löbmann K. The role interplay between mesoporous silica pore volume and surface area and their effect on drug loading capacity. Int J Pharm X. 2019;1:Article 100008. | 미소장 |
| 44 | Shahidi M, Abazari O, Dayati P, Bakhshi A, Zavarreza J, Modarresi MH, Haghiralsadat F, Rahmanian M, Naghib SM, Tofighi D. Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy. Front Bioeng Biotechnol. 2022;10:949704. | 미소장 |
| 45 | Nguyen TL, Cha BG, Choi Y, Im J, Kim J. Injectable dualscale mesoporous silica cancer vaccine enabling efficient delivery of antigen/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold. Biomaterials. 2020;239:Article 119859. | 미소장 |
| 46 | Mahony D, Cavallaro AS, Stahr F, Mahony TJ, Qiao SZ, Mitter N. Mesoporous silica nanoparticles act as a selfadjuvant for ovalbumin model antigen in mice. Small. 2013;9(18):3138–3146. | 미소장 |
| 47 | Hong X, Zhong X, Du G, Hou Y, Zhang Y, Zhang Z, Gong T, Zhang L, Sun X. The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency. Sci Adv. 2024;6(25):eaaz4462. | 미소장 |
| 48 | Lin X, Li F, Guan J, Wang X, Yao C, Zeng Y, Liu X. Janus silica nanoparticle-based tumor microenvironment modulator for restoring tumor sensitivity to programmed cell death ligand 1 immune checkpoint blockade therapy. ACS Nano. 2023;17(15):14494–14507. | 미소장 |
| 49 | Huang Y, Mao K, Zhang B, Zhao Y. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual targetspecific drug delivery and MRI in cancer theranostics. Mater Sci Eng C. 2017;70(Pt 1):763–771. | 미소장 |
| 50 | Estelrich J, Escribano E, Queralt J, Busquets MA. Iron oxide nanoparticles for magnetically-guided and magneticallyresponsive drug delivery. Int J Mol Sci. 2015;16(4):8070–8101. | 미소장 |
| 51 | Mejías R, Pérez-Yagüe S, Gutiérrez L, Cabrera LI, Spada R, Acedo P, Serna CJ, Lázaro FJ, Villanueva Á, del P. Morales M, et al. Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy. Biomaterials. 2011;32(11):2938–2952. | 미소장 |
| 52 | Cho N-H, Cheong T-C, Min JH, Wu JH, Lee SJ, Kim D, Yang J-S, Kim S, Kim YK, Seong S-Y. A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat Nanotechnol. 2011;6(10):675–682. | 미소장 |
| 53 | Huang J, Bu L, Xie J, Chen K, Cheng Z, Li X, Chen X. Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano. 2010;4(12):7151–7160. | 미소장 |
| 54 | Cortés-Llanos B, Ocampo SM, de la Cueva L, Calvo GF, Belmonte-Beitia J, Pérez L, Salas G, Ayuso-Sacido Á. Influence of coating and size of magnetic nanoparticles on cellular uptake for in vitro MRI. Nanomaterials. 2021;11(11):2888. | 미소장 |
| 55 | Jeon M, Lin G, Stephen ZR, Kato FL, Zhang M. Paclitaxelloaded iron oxide nanoparticles for targeted breast cancer therapy. Adv Ther. 2019;2(12):1900081. | 미소장 |
| 56 | Zheng S, Tian Y, Ouyang J, Shen Y, Wang X, Luan J. Carbon nanomaterials for drug delivery and tissue engineering. Front Chem. 2022;10:Article 990362. | 미소장 |
| 57 | Liu W, Speranza G. Functionalization of carbon nanomaterials for biomedical applications. C. 2019;5(4):72. | 미소장 |
| 58 | Debnath SK, Srivastava R. Drug delivery with carbonbased nanomaterials as versatile nanocarriers: Progress and prospects. Front Nanotechnol. 2021;3:644564. | 미소장 |
| 59 | Mashal A, Sitharaman B, Li X, Avti PK, Sahakian AV, Booske JH, Hagness SC. Toward carbon-nanotube-based theranostic agents for microwave detection and treatment of breast cancer: Enhanced dielectric and heating response of tissue-mimicking materials. IEEE Trans Biomed Eng. 2010;57(8):1831–1834. | 미소장 |
| 60 | Golubewa L, Timoshchenko I, Romanov O, Karpicz R, Kulahava T, Rutkauskas D, Shuba M, Dementjev A, Svirko Y, Kuzhir P. Single-walled carbon nanotubes as a photo-thermoacoustic cancer theranostic agent: Theory and proof of the concept experiment. Sci Rep. 2020;10(1):22174. | 미소장 |
| 61 | Tang L, Zhang A, Mei Y, Xiao Q, Xu X, Wang W. NIR light-triggered chemo-phototherapy by ICG functionalized MWNTs for synergistic tumor-targeted delivery. Pharmaceutics. 2021;13(12):2145. | 미소장 |
| 62 | Zhao Y, Zhao T, Cao Y, Sun J, Zhou Q, Chen H, Guo S, Wang Y, Zhen Y, Liang X-J, et al. Temperature-sensitive lipid-coated carbon nanotubes for synergistic photothermal therapy and gene therapy. ACS Nano. 2021;15(4):6517–6529. | 미소장 |
| 63 | Hassan HAFM, Smyth L, Wang JT-W, Costa PM, Ratnasothy K, Diebold SS, Lombardi G, Al-Jamal KT. Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy. Biomaterials. 2016;104:310–322. | 미소장 |
| 64 | Zhao D, Alizadeh D, Zhang L, Liu W, Farrukh O, Manuel E, Diamond DJ, Badie B. Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity. Clin Cancer Res. 2011;17(4):771–782. | 미소장 |
| 65 | Fadel TR, Steenblock ER, Stern E, Li N, Wang X, Haller GL, Pfefferle LD, Fahmy TM. Enhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuli. Nano Lett. 2008;8(7):2070–2076. | 미소장 |
| 66 | Fadel TR, Look M, Staffier PA, Haller GL, Pfefferle LD, Fahmy TM. Clustering of stimuli on single-walled carbon nanotube bundles enhances cellular activation. Langmuir. 2010;26(8):5645–5654. | 미소장 |
| 67 | Yu W, Sisi L, Haiyan Y, Jie L. Progress in the functional modification of graphene/graphene oxide: A review. RSC Adv. 2020;10(26):15328–15345. | 미소장 |
| 68 | Aliyev E, Filiz V, Khan MM, Lee YJ, Abetz C, Abetz V. Structural characterization of graphene oxide: Surface functional groups and fractionated oxidative debris. Nanomaterials. 2019;9(8):1180 . | 미소장 |
| 69 | Zhuang W-R, Wang Y, Cui P-F, Xing L, Lee J, Kim D, Jiang H-L, Oh Y-K. Applications of π-π stacking interactions in the design of drug-delivery systems. J Control Release. 2019;294:311–326. | 미소장 |
| 70 | Yin Y, Li X, Ma H, Zhang J, Yu D, Zhao R, Yu S, Nie G, Wang H. In situ transforming RNA nanovaccines from polyethylenimine functionalized graphene oxide hydrogel for durable cancer immunotherapy. Nano Lett. 2021;21(5):2224–2231. | 미소장 |
| 71 | Luo L, Liu C, He T, Zeng L, Xing J, Xia Y, Pan Y, Gong C, Wu A. Engineered fluorescent carbon dots as promising immune adjuvants to efficiently enhance cancer immunotherapy. Nanoscale. 2018;10(46):22035–22043. | 미소장 |
| 72 | Qiu C, Wu Y, Guo Q, Shi Q, Zhang J, Meng Y, Xia F, Wang J. Preparation and application of calcium phosphate nanocarriers in drug delivery. Mater Today Bio. 2022;17:Article 100501. | 미소장 |
| 73 | Cai R-Q, Liu D-Z, Cui H, Cheng Y, Liu M, Zhang B-L, Mei Q-B, Zhou S-Y. Charge reversible calcium phosphate lipid hybrid nanoparticle for siRNA delivery. Oncotarget. 2017;8(26):42772–42788. | 미소장 |
| 74 | Li Q, Chao Y, Liu B, Xiao Z, Yang Z, Wu Y, Liu Z. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy. Biomaterials. 2022;291:Article 121880. | 미소장 |
| 75 | Zhang X, Wei M, Zhang Z, Zeng Y, Zou F, Zhang S, Wang Z, Chen F, Xiong H, Li Y, et al. Risedronatefunctionalized manganese-hydroxyapatite amorphous particles: A potent adjuvant for subunit vaccines and cancer immunotherapy. J Control Release. 2024;367:13–26. | 미소장 |
| 76 | Sun B, Zhao X, Gu W, Cao P, Movahedi F, Wu Y, Xu ZP, Gu W. ATP stabilised and sensitised calcium phosphate nanoparticles as effective adjuvants for a DNA vaccine against cancer. J Mater Chem B. 2021;9(36):7435–7446. | 미소장 |
| 77 | Haque S, Tripathy S, Patra CR. Manganese-based advanced nanoparticles for biomedical applications: Future opportunity and challenges. Nanoscale. 2021;13(39):16405–16426. | 미소장 |
| 78 | Prasad P, Gordijo CR, Abbasi AZ, Maeda A, Ip A, Rauth AM, DaCosta RS, Wu XY. Multifunctional albumin–MnO2nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response. ACS Nano. 2014;8(4):3202–3212. | 미소장 |
| 79 | Sobańska Z, Roszak J, Kowalczyk K, Stępnik M. Applications and biological activity of nanoparticles of manganese and manganese oxides in in vitro and in vivo models. Nanomaterials. 2021;11(5):1084. | 미소장 |
| 80 | Sun Y, Wang Y, Liu Y, Wang H, Yang C, Liu X, Wang F. Integration of manganese dioxide-based nanomaterials for biomedical applications. Adv NanoBiomed Res. 2023;3(1):2200093. | 미소장 |
| 81 | Alsharif NB, Bere K, Sáringer S, Samu GF, Takács D, Hornok V, Szilagyi I. Design of hybrid biocatalysts by controlled heteroaggregation of manganese oxide and sulfate latex particles to combat reactive oxygen species. J Mater Chem B. 2021;9(24):4929–4940. | 미소장 |
| 82 | Bellusci M, La Barbera A, Padella F, Mancuso M, Pasquo A, Grollino MG, Leter G, Nardi E, Cremisini C, Giardullo P, et al. Biodistribution and acute toxicity of a nanofluid containing manganese iron oxide nanoparticles produced by a mechanochemical process. Int J Nanomedicine. 2014;9:1919–1929. | 미소장 |
| 83 | Deng Z, Xi M, Zhang C, Wu X, Li Q, Wang C, Fang H, Sun G, Zhang Y, Yang G, et al. Biomineralized MnO2 nanoplatforms mediated delivery of immune checkpoint inhibitors with STING pathway activation to potentiate cancer radioimmunotherapy. ACS Nano. 2023;17:4495–4506. | 미소장 |
| 84 | Song T, Liao Y, Zuo Q, Liu N, Liu Z. MnO2 nanoparticles as a minimalist multimode vaccine adjuvant/delivery system to regulate antigen presenting cells for tumor immunotherapy. J Mater Chem B. 2022;10(18):3474–3490. | 미소장 |
| 85 | Cai X, Zhu Q, Zeng Y, Zeng Q, Chen X, Zhan Y. Manganese oxide nanoparticles as MRI contrast agents in tumor multimodal imaging and therapy. Int J Nanomedicine. 2019;14:8321–8344. | 미소장 |
| 86 | Yen T-YC, Abbasi AZ, He C, Lip H-Y, Park E, Amini MA, Adissu HA, Foltz W, Rauth AM, Henderson J, et al. Biocompatible and bioactivable terpolymer-lipid-MnO2 nanoparticle-based MRI contrast agent for improving tumor detection and delineation. Mater Today Bio. 2024;25:Article 100954. | 미소장 |
| 87 | Zhao Y, Qu Y, Hao C, Yao W. PD-1/PD-L1 axis in organ fibrosis. Front Immunol. 2023;14:1145682. | 미소장 |
| 88 | Dutta S, Ganguly A, Chatterjee K, Spada S, Mukherjee S. Targets of immune escape mechanisms in cancer: Basis for development and evolution of cancer immune checkpoint inhibitors. Biology. 2023;12(12):218. | 미소장 |
| 89 | Xu S, Wang C, Yang L, Wu J, Li M, Xiao P, Xu Z, Xu Y, Wang K. Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy. Front Immunol. 2023;14:1199631. | 미소장 |
| 90 | Han Y, Liu D, Li L. PD-1/PD-L1 pathway: Current researches in cancer. Am J Cancer Res. 2020;10(3):727–742. | 미소장 |
| 91 | Li X, Yang Y, Huang Q, Deng Y, Guo F, Wang G, Liu M. Crosstalk between the tumor microenvironment and cancer cells: A promising predictive biomarker for immune checkpoint inhibitors. Front Cell Dev Biol. 2021;9:Article 738373. | 미소장 |
| 92 | Sharon E, Streicher H, Goncalves P, Chen HX. Immune checkpoint inhibitors in clinical trials. Chin J Cancer. 2014;33(9):434–444. | 미소장 |
| 93 | Alturki NA. Review of the immune checkpoint inhibitors in the context of cancer treatment. J Clin Med. 2023;12(13):4301. | 미소장 |
| 94 | Martins F, Sofiya L, Sykiotis GP, Lamine F, Maillard M, Fraga M, Shabafrouz K, Ribi C, Cairoli A, Guex-Crosier Y, et al. Adverse effects of immune-checkpoint inhibitors:Epidemiology, management and surveillance. Nat Rev Clin Oncol. 2019;16(9):563–580. | 미소장 |
| 95 | Conroy M, Naidoo J. Immune-related adverse events and the balancing act of immunotherapy. Nat Commun. 2022;13(1):392. | 미소장 |
| 96 | Grossman JE, Vasudevan D, Joyce CE, Hildago M. Is PD-L1 a consistent biomarker for anti-PD-1 therapy? The model of balstilimab in a virally-driven tumor. Oncogene. 2021;40(8):1393–1395. | 미소장 |
| 97 | Jiang C, Cao SR, Li N, Jiang L, Sun T. PD-1 and PD-L1correlated gene expression profiles and their association with clinical outcomes of breast cancer. Cancer Cell Int. 2019;19:2333. | 미소장 |
| 98 | Wu Y, Chen W, Xu ZP, Gu W. PD-L1 distribution and perspective for cancer immunotherapy—Blockade, knockdown, or inhibition. Front Immunol. 2019;10:2022. | 미소장 |
| 99 | Wu Q, Jiang L, Li S-C, He Q-J, Yang B, Cao J. Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway. Acta Pharmacol Sin. 2021;42(1):1–9. | 미소장 |
| 100 | Wang Z, Wu X. Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker. Cancer Med. 2020;9(21):8086–8121. | 미소장 |
| 101 | Sun JY, Zhang D, Wu S, Xu M, Zhou X, Lu XJ, Ji J. Resistance to PD-1/PD-L1 blockade cancer immunotherapy:Mechanisms, predictive factors, and future perspectives. Biomark Res. 2020;8:35. | 미소장 |
| 102 | Wang G, Wu W, Yang H, Zhang P, Wang J-Y. Intact polyaniline coating as a conductive guidance is beneficial to repairing sciatic nerve injury. J Biomed Mater Res Part B Appl Biomater. 2020;108:128–142. | 미소장 |
| 103 | Liu H, Xu C, Meng M, Li S, Sheng S, Zhang S, Ni W, Tian H, Wang Q. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer. Acta Biomater. 2022;144:132–141. | 미소장 |
| 104 | Alsaiari SK, Qutub SS, Sun S, Baslyman W, Aldehaiman M, Alyami M, Almalik A, Halwani R, Merzaban J, Mao Z, et al. Sustained and targeted delivery of checkpoint inhibitors by metal-organic frameworks for cancer immunotherapy. Sci Adv. 2021;7:eabe7174. | 미소장 |
| 105 | Yang YSS, Moynihan KD, Bekdemir A, Dichwalkar TM, Noh MM, Watson N, Melo M, Ingram J, Suh H, Ploegh H, et al. Targeting small molecule drugs to T cells with antibody-directed cell-penetrating gold nanoparticles. Biomater Sci. 2018;7:113–124. | 미소장 |
| 106 | Chu H, Zhao J, Mi Y, Di Z, Li L. NIR-light-mediated spatially selective triggering of anti-tumor immunity via upconversion nanoparticle-based immunodevices. Nat Commun. 2019;10(1):2839. | 미소장 |
| 107 | Reda M, Ngamcherdtrakul W, Nelson MA, Siriwon N, Wang R, Zaidan HY, Bejan DS, Reda S, Hoang NH, Crumrine NA, et al. Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment. Nat Commun. 2022;13(1):4261. | 미소장 |
| 108 | Liu B, Cao W, Qiao G, Yao S, Pan S, Wang L, Yue C, Ma L, Liu Y, Cui D. Effects of gold nanoprism-assisted human PDL1siRNA on both gene down-regulation and photothermal therapy on lung cancer. Acta Biomater. 2019;99:307–319. | 미소장 |
| 109 | Pandey R, Yang F-S, Sivasankaran VP, Lo Y-L, Wu Y-T, Chang C-Y, Chiu C-C, Liao Z-X, Wang L-F. Comparing the variants of iron oxide nanoparticle-mediated delivery of miRNA34a for efficiency in silencing of PD-L1 genes in cancer cells. Pharmaceutics. 2023;15(1):215. | 미소장 |
| 110 | Ge R, Liu C, Zhang X, Wang W, Li B, Liu J, Liu Y, Sun H, Zhang D, Hou Y, et al. Photothermal-activatable Fe3O4 superparticle nanodrug carriers with PD-L1immune checkpoint blockade for anti-metastatic cancer immunotherapy. ACS Appl Mater Interfaces. 2018;10(24):20342–20355. | 미소장 |
| 111 | Ge Y-X, Zhang T-W, Zhou L, Ding W, Liang H-F, Hu Z-C, Chen Q, Dong J, Xue F-F, Yin X-F, et al. Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework. Biomaterials. 2022;282:Article 121407. | 미소장 |
| 112 | Yan C, Liu Y, Zhao G, Yang H, Lv H, Li G, Li Y, Fu Y, Sun F, Feng Y, et al. Inhalable metal–organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy. Acta Pharm Sin B. 2024;14(5):2281–2297. | 미소장 |
| 113 | Li Z, Bu J, Zhu X, Zhou H, Ren K, Chu PK, Li L, Hu X, Ding X. Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1siRNAs. Biomater Adv. 2022;136:Article 212761. | 미소장 |
| 114 | Liu Y, Yang J, Liu B, Cao W, Zhang J, Yang Y, Ma L, de la Fuente JM, Song J, Ni J, et al. Human iPS cells loaded with MnO2-based nanoprobes for photodynamic and simultaneous enhanced immunotherapy against cancer. Nanomicro Lett. 2020;12(1):127. | 미소장 |
| 115 | Grippin AJ, Wummer B, Wildes T, Dyson K, Trivedi V, Yang C, Sebastian M, Mendez-Gomez HR, Padala S, Grubb M, et al. Dendritic cell-activating magnetic nanoparticles enable early prediction of antitumor response with magnetic resonance imaging. ACS Nano. 2019;13(12):13884–13898. | 미소장 |
| 116 | Gardner D, Jeffery LE, Sansom DM. Understanding the CD28/CTLA-4 (CD152) pathway and its implications for costimulatory blockade. Am J Transplant. 2014;14(9):1985–1991. | 미소장 |
| 117 | Chikuma S. CTLA-4, an essential immune-checkpoint for T-cell activation. Curr Top Microbiol Immunol. 2017;410:99–126. | 미소장 |
| 118 | Rowshanravan B, Halliday N, Sansom DM. CTLA-4: A moving target in immunotherapy. Blood. 2018;131(1):58–67. | 미소장 |
| 119 | Crepeau RL, Ford ML. Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity. Expert Opin Biol Ther. 2017;17(8):1001–1012. | 미소장 |
| 120 | Hajihassan Z, Afsharian NP, Ansari-Pour N. In silico engineering a CD80 variant with increased affinity to CTLA-4 and decreased affinity to CD28 for optimized cancer immunotherapy. J Immunol Methods. 2023;513:Article 113425. | 미소장 |
| 121 | Ji H-H, Tang X-W, Dong Z, Song L, Jia Y-T. Adverse event profiles of anti-CTLA-4 and anti-PD-1 monoclonal antibodies alone or in combination: Analysis of spontaneous reports submitted to FAERS. Clin Drug Investig. 2019;39(3):319–330. | 미소장 |
| 122 | Wang C, Xu L, Liang C, Xiang J, Peng R, Liu Z. Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis. Adv Mater. 2014;26(48):8154–8162. | 미소장 |
| 123 | Li M, Lin C, Shen A, Ma X, Ni J, Wu J, Wang W, Wang P, Gao X. A smart responsive nanotheranostic system for MRI of tumor response to immunotherapy and enhanced synergism of thermo-immunotherapy. Adv Funct Mater. 2024;34(23):2315171. | 미소장 |
| 124 | Jiang H, Fu H, Guo Y, Hu P, Shi J. Evoking tumor associated macrophages by mitochondria-targeted magnetothermal immunogenic cell death for cancer immunotherapy. Biomaterials. 2022;289:Article 121799. | 미소장 |
| 125 | Bol KF, Schreibelt G, Gerritsen WR, de Vries IJM, Figdor CG. Dendritic cell–based immunotherapy: State of the art and beyond. Clin Cancer Res. 2016;22(8):1897–1906. | 미소장 |
| 126 | Sabado RL, Balan S, Bhardwaj N. Dendritic cell-based immunotherapy. Cell Res. 2017;27(1):74–95. | 미소장 |
| 127 | Ghasemi A, Martinez-Usatorre A, Li L, Hicham M, Guichard A, Marcone R, Fournier N, Torchia B, Martinez Bedoya D, Davanture S, et al. Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy. Nat Cancer. 2024;5(2):240–261. | 미소장 |
| 128 | Seong J, Jeong S, Kim S, Yun S, Baek Y, Kim K. Ex vivo activation of dendritic cells via coacervate-mediated exogenous tumor cell lysate delivery. Biomater Sci. 2023;11(13):4537–4548. | 미소장 |
| 129 | Zhao Y, Qiao G, Wang X, Song Y, Zhou X, Jiang N, Zhou L, Huang H, Zhao J, Morse MA, et al. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients:A prospective patients’ preference-based study (PPPS). Clin Transl Oncol. 2019;21(6):721–728. | 미소장 |
| 130 | Smith R, Wafa EI, Geary SM, Ebeid K, Alhaj-Suliman SO, Salem AK. Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine. Sci Adv. 2024;8(29):eabk3150. | 미소장 |
| 131 | Han D, Liu J, Chen C, Dong L, Liu Y, Chang R, Huang X, Liu Y, Wang J, Dougherty U, et al. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature. 2019;566(7743):270–274. | 미소장 |
| 132 | Ouyang Z, Gao Y, Yang R, Shen M, Shi X. Genetic engineering of dendritic cells using partially zwitterionic dendrimerentrapped gold nanoparticles boosts efficient tumor immunotherapy. Biomacromolecules. 2022;23(3):1326–1336. | 미소장 |
| 133 | Kim WG, Choi B, Yang H-J, Han J-A, Jung H, Cho H, Kang S, Hong SY. Covalent conjugation of small-molecule adjuvants to nanoparticles induces robust cytotoxic T cell responses via DC activation. Bioconjug Chem. 2016;27(9):2007–2013. | 미소장 |
| 134 | Hanlon DJ, Aldo PB, Devine L, Alvero AB, Engberg AK, Edelson R, Mor G. Enhanced stimulation of anti-ovarian cancer CD8+ T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen. Am J Reprod Immunol. 2011;65(6):597–609. | 미소장 |
| 135 | Zeng Z, Pu K. Improving cancer immunotherapy by cell membrane-camouflaged nanoparticles. Adv Funct Mater. 2020;30(43):2004397. | 미소장 |
| 136 | Cheng S, Xu C, Jin Y, Li Y, Zhong C, Ma J, Yang J, Zhang N, Li Y, Wang C, et al. Artificial mini dendritic cells boost T cell–based immunotherapy for ovarian cancer. Adv Sci. 2020;7(7):1903301. | 미소장 |
| 137 | Raza F, Zafar H, Zhang S, Kamal Z, Su J, Yuan W-E, Mingfeng Q. Recent advances in cell membrane-derived biomimetic nanotechnology for cancer immunotherapy. Adv Healthc Mater. 2021;10(6):e2002081. | 미소장 |
| 138 | Li C, Jiang P, Wei S, Xu X, Wang J. Regulatory T cells in tumor microenvironment: New mechanisms, potential therapeutic strategies and future prospects. Mol Cancer. 2020;19(1):116. | 미소장 |
| 139 | Sterner RC, Sterner RM. CAR-T cell therapy: Current limitations and potential strategies. Blood Cancer J. 2021;11:69. | 미소장 |
| 140 | Xin T, Cheng L, Zhou C, Zhao Y, Hu Z, Wu X. In-vivo induced CAR-T cell for the potential breakthrough to overcome the barriers of current CAR-T cell therapy. Front Oncol. 2022;12:Article 809754. | 미소장 |
| 141 | Wang X, Meng F, Yen Y-T, Li R, Liu B. Nanotechnology-based CAR-T strategies for improving efficacy and safety of tumor immunotherapy. Adv Funct Mater. 2021;31(1):2004713. | 미소장 |
| 142 | Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021;22(13):6995. | 미소장 |
| 143 | Gao J, Liang Y, Wang L. Shaping polarization of tumorassociated macrophages in cancer immunotherapy. Front Immunol. 2022;13:Article 888713. | 미소장 |
| 144 | Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, Rao L, Duo Y. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8(1):207. | 미소장 |
| 145 | Monnier M, Paolini L, Vinatier E, Mantovani A, Delneste Y, Jeannin P. Antitumor strategies targeting macrophages: The importance of considering the differences in differentiation/polarization processes between human and mouse macrophages. J Immunother Cancer. 2022;10(10):e005560. | 미소장 |
| 146 | Duan Z, Luo Y. Targeting macrophages in cancer immunotherapy. Signal Transduct Target Ther. 2021;6(1):127. | 미소장 |
| 147 | Kashfi K, Kannikal J, Nath N. Macrophage reprogramming and cancer therapeutics: Role of iNOS-derived NO. Cells. 2021;10(11):3194. | 미소장 |
| 148 | Wang P, Geng J, Gao J, Zhao H, Li J, Shi Y, Yang B, Xiao C, Linghu Y, Sun X, et al. Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2axis. Nat Commun. 2019;10(1):755. | 미소장 |
| 149 | Canton M, Sánchez-Rodríguez R, Spera I, Venegas FC, Favia M, Viola A, Castegna A. Reactive oxygen species in macrophages: Sources and targets. Front Immunol. 2021;12:Article 734229. | 미소장 |
| 150 | Rath M, Müller I, Kropf P, Closs EI, Munder M. Metabolism via arginase or nitric oxide synthase: Two competing arginine pathways in macrophages. Front Immunol. 2014;5:532. | 미소장 |
| 151 | Latour YL, Gobert AP, Wilson KT. The role of polyamines in the regulation of macrophage polarization and function. Amino Acids. 2020;52(2):151–160. | 미소장 |
| 152 | Shen K-Y, Song Y-C, Chen I-H, Chong P, Liu S-J. Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a toll-like receptor agonist-conjugated peptide. Hum Vaccin Immunother. 2014;10(11):3241–3250. | 미소장 |
| 153 | Liu J, Geng X, Hou J, Wu G. New insights into M1/M2macrophages: Key modulators in cancer progression. Cancer Cell Int. 2021;21(1):389. | 미소장 |
| 154 | Chen P-M, Pan W-Y, Luo P-K, Phung HN, Liu Y-M, Chiang M-C, Chang W-A, Tien T-L, Huang C-Y, Wu W-W, et al. Pollen-mimetic metal–organic frameworks with tunable spike-like nanostructures that promote cell interactions to improve antigen-specific humoral immunity. ACS Nano. 2021;15(4):7596–7607. | 미소장 |
| 155 | Wang W, Wang P, Tang X, Elzatahry AA, Wang S, Al-Dahyan D, Zhao M, Yao C, Hung C-T, Zhu X, et al. Facile synthesis of uniform virus-like mesoporous silica nanoparticles for enhanced cellular internalization. ACS Cent. Sci. 2017;3(8):839–846. | 미소장 |
| 156 | Luo Y-H, Wu ZW, Tsai H-T, Lin S-Y, Lin P. Endotoxin nanovesicles: Hydrophilic gold nanodots control supramolecular lipopolysaccharide assembly for modulating immunological responses. Nano Lett. 2015;15(10):6446–6453. | 미소장 |
| 157 | Lavie D, Ben-Shmuel A, Erez N, Scherz-Shouval R. Cancerassociated fibroblasts in the single-cell era. Nat Cancer. 2022;3(7):793–807. | 미소장 |
| 158 | Han C, Liu T, Yin R. Biomarkers for cancer-associated fibroblasts. Biomark Res. 2020;8(1):64. | 미소장 |
| 159 | Kieffer Y, Hocine HR, Gentric G, Pelon F, Bernard C, Bourachot B, Lameiras S, Albergante L, Bonneau C, Guyard A, et al. Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. Cancer Discov. 2020;10(9):1330–1351. | 미소장 |
| 160 | Thiery J. Modulation of the antitumor immune response by cancer-associated fibroblasts: Mechanisms and targeting strategies to hamper their immunosuppressive functions. Explor Target Antitumor Ther. 2022;3(5):598–629. | 미소장 |
| 161 | Liu T, Han C, Wang S, Fang P, Ma Z, Xu L, Yin R. Cancerassociated fibroblasts: An emerging target of anti-cancer immunotherapy. J Hematol Oncol. 2019;12(1):86. | 미소장 |
| 162 | Zhang C, Fei Y, Wang H, Hu S, Liu C, Hu R, Du Q. CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy. Front Pharmacol. 2023;14:1113378. | 미소장 |
| 163 | Barrett RL, Puré E. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy. eLife. 2020;9:e57243. | 미소장 |
| 164 | Zhou W, Guo S, Liu M, Burow ME, Wang G. Targeting CXCL12/CXCR4 axis in tumor immunotherapy. Curr Med Chem. 2019;26(17):3026–3041. | 미소장 |
| 165 | Andorko JI, Tostanoski LH, Solano E, Mukhamedova M, Jewell CM. Intra-lymph node injection of biodegradable polymer particles. J Vis Exp. 2014;(83):Article e50984. | 미소장 |
| 166 | Kato S, Shirai Y, Sakamoto M, Mori S, Kodama T. Use of a lymphatic drug delivery system and sonoporation to target malignant metastatic breast cancer cells proliferating in the marginal sinuses. Sci Rep. 2019;9:13242. | 미소장 |
| 167 | Li Z-Z, Zhong N-N, Cao L-M, Cai Z-M, Xiao Y, Wang G-R, Liu B, Xu C, Bu L-L. Nanoparticles targeting lymph nodes for cancer immunotherapy: Strategies and influencing factors. Small. 2024;20(19):2308731. | 미소장 |
| 168 | Moon JJ, Huang B, Irvine DJ. Engineering nanoand microparticles to tune immunity. Adv Mater. 2012;24(28):3724–3746. | 미소장 |
| 169 | Zhu G, Zhang F, Ni Q, Niu G, Chen X. Efficient nanovaccine delivery in cancer immunotherapy. ACS Nano. 2017;11(3):2387–2392. | 미소장 |
| 170 | Lambert LA, Gibson GR, Maloney M, Durell B, Noelle RJ, Barth RJ Jr. Intranodal immunization with tumor lysatepulsed dendritic cells enhances protective antitumor Immunity1. Cancer Res. 2001;61(2):641–646. | 미소장 |
| 171 | Lesimple T, Neidhard E-M, Vignard V, Lefeuvre C, Adamski H, Labarrière N, Carsin A, Monnier D, Collet B, Clapisson G, et al. Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients. Clin Cancer Res. 2006;12(24):7380–7388. | 미소장 |
| 172 | Gilliet M, Kleinhans M, Lantelme E, Schadendorf D, Burg G, Nestle FO. Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1responses to protein neoantigen. Blood. 2003;102(1):36–42. | 미소장 |
| 173 | Murthy V, Minehart J, Sterman DH. Local immunotherapy of cancer: Innovative approaches to harnessing tumor-specific immune responses. J Natl Cancer Inst. 2017;109(12):djx097. | 미소장 |
| 174 | Sukhbaatar A, Mori S, Kodama T. Intranodal delivery of modified docetaxel: Innovative therapeutic method to inhibit tumor cell growth in lymph nodes. Cancer Sci. 2022;113(4):1125–1139. | 미소장 |
| 175 | Zinkhan S, Ogrina A, Balke I, Reseviča G, Zeltins A, de Brot S, Lipp C, Chang X, Zha L, Vogel M, et al. The impact of size on particle drainage dynamics and antibody response. J Control Release. 2021;331:296–308. | 미소장 |
| 176 | Kjellman P, Fredriksson S, Kjellman C, Strand S-E, In ’t Zandt R. Size-dependent lymphatic uptake of nanoscaletailored particles as tumor mass increases. Future Sci OA. 2015;1(4):FSO60. | 미소장 |
| 177 | Howard GP, Verma G, Ke X, Thayer WM, Hamerly T, Baxter VK, Lee JE, Dinglasan RR, Mao H-Q. Critical size limit of biodegradable nanoparticles for enhanced lymph node trafficking and paracortex penetration. Nano Res. 2019;12(4):837–844. | 미소장 |
| 178 | Fromen CA, Rahhal TB, Robbins GR, Kai MP, Shen TW, Luft JC, DeSimone JM. Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells. Nanomedicine. 2016;12(3):677–687. | 미소장 |
| 179 | Ke X, Howard GP, Tang H, Cheng B, Saung MT, Santos JL, Mao H-Q. Physical and chemical profiles of nanoparticles for lymphatic targeting. Adv Drug Deliv Rev. 2019;151–152:72–93. | 미소장 |
| 180 | Yuan Z, Li Y, Zhang S, Wang X, Dou H, Yu X, Zhang Z, Yang S, Xiao M. Extracellular matrix remodeling in tumor progression and immune escape: From mechanisms to treatments. Mol Cancer. 2023;22:48. | 미소장 |
| 181 | Henke E, Nandigama R, Ergün S. Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front Mol Biosci. 2020;6:160. | 미소장 |
| 182 | Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437. | 미소장 |
| 183 | Neophytou CM, Panagi M, Stylianopoulos T, Papageorgis P. The role of tumor microenvironment in cancer metastasis:Molecular mechanisms and therapeutic opportunities. Cancers (Basel). 2021;13(9):2053. | 미소장 |
| 184 | Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T, Zare P. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. 2020;18(1):59. | 미소장 |
| 185 | Serpa J. Metabolic remodeling as a way of adapting to tumor microenvironment (TME), a job of several holders. Adv Exp Med Biol. 2020;1219:1–34. | 미소장 |
| 186 | Nakahara R, Maeda K, Aki S, Osawa T. Metabolic adaptations of cancer in extreme tumor microenvironments. Cancer Sci. 2023;114(4):1200–1207. | 미소장 |
| 187 | Babar Q, Saeed A, Tabish TA, Sarwar M, Thorat ND. Targeting the tumor microenvironment: Potential strategy for cancer therapeutics. Biochim Biophys Acta Mol Basis Dis. 2023;1869(6):Article 166746. | 미소장 |
| 188 | Pitt JM, Marabelle A, Eggermont A, Soria J-C, Kroemer G, Zitvogel L. Targeting the tumor microenvironment:Removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. 2016;27(8):1482–1492. | 미소장 |
| 189 | Wen Y, Zhu Y, Zhang C, Yang X, Gao Y, Li M, Yang H, Liu T, Tang H. Chronic inflammation, cancer development and immunotherapy. Front Pharmacol. 2022;13:1040163. | 미소장 |
| 190 | Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: Signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6(1):263. | 미소장 |
| 191 | Tie Y, Tang F, Wei Y-Q, Wei X-W. Immunosuppressive cells in cancer: Mechanisms and potential therapeutic targets. J Hematol Oncol. 2022;15(1):61. | 미소장 |
| 192 | Zhong S, Jeong J-H, Chen Z, Chen Z, Luo J-L. Targeting tumor microenvironment by small-molecule inhibitors. Transl Oncol. 2020;13(1):57–69. | 미소장 |
| 193 | Park D, Lee SJ, Park J-W. Aptamer-based smart targeting and spatial trigger–response drug-delivery systems for anticancer therapy. Biomedicines. 2024;12(1):187. | 미소장 |
| 194 | Uthaman S, Huh KM, Park I-K. Tumor microenvironmentresponsive nanoparticles for cancer theragnostic applications. Biomater Res. 2018;22:22. | 미소장 |
| 195 | Subhan MA, Parveen F, Filipczak N, Yalamarty SSK, Torchilin VP. Approaches to improve EPR-based drug delivery for cancer therapy and diagnosis. J Pers Med. 2023;13(3):389. | 미소장 |
| 196 | Crittenden MR, Thanarajasingam U, Vile RG, Gough MJ. Intratumoral immunotherapy: Using the tumour against itself. Immunology. 2005;114:11–22. | 미소장 |
| 197 | Melero I, Castanon E, Alvarez M, Champiat S, Marabelle A. Intratumoural administration and tumour tissue targeting of cancer immunotherapies. Nat Rev Clin Oncol. 2021;18:558–576. | 미소장 |
| 198 | Marabelle A, Tselikas L, de Baere T, Houot R. Intratumoral immunotherapy: Using the tumor as the remedy. Ann Oncol. 2017;28:xii33–xii43. | 미소장 |
| 199 | Le Louedec F, Leenhardt F, Marin C, Chatelut É, Evrard A, Ciccolini J. Cancer immunotherapy dosing: A pharmacokinetic/pharmacodynamic perspective. Vaccines. 2020;8(4):632. | 미소장 |
| 200 | Maker AV, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Hughes M, Yellin MJ, Haworth LR, Levy C, et al. Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma. J Immunother. 2006;29(4):455–463. | 미소장 |
| 201 | Xu P, Liang F. Nanomaterial-based tumor photothermal immunotherapy. Int J Nanomedicine. 2020;15:9159–9180. | 미소장 |
| 202 | Lu Y, Sun W, Du J, Fan J, Peng X. Immuno-photodynamic therapy (IPDT): Organic photosensitizers and their application in cancer ablation. JACS Au. 2023;3:682–699. | 미소장 |
| 203 | Sordo-Bahamonde C, Lorenzo-Herrero S, Gonzalez-Rodriguez AP, Martínez-Pérez A, Rodrigo JP, García-Pedrero JM, Gonzalez S. Chemo-immunotherapy: A new trend in cancer treatment. Cancers. 2023;15(11):2912. | 미소장 |
| 204 | Zhang Z, Liu X, Chen D, Yu J. Radiotherapy combined with immunotherapy: The dawn of cancer treatment. Signal Transduct Target Ther. 2022;7(1):258. | 미소장 |
| 205 | Zhai J, Gu X, Liu Y, Hu Y, Jiang Y, Zhang Z. Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review. Front Pharmacol. 2023;14:1152934. | 미소장 |
| 206 | Liu J, Li Z, Zhao D, Feng X, Wang C, Li D, Ding J. Immunogenic cell death-inducing chemotherapeutic nanoformulations potentiate combination chemoimmunotherapy. Mater Des. 2021;202:Article 109465. | 미소장 |
| 207 | Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, Gu Z, Ma X, Luo K. Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency. Adv Sci. 2022;9(22):2201734. | 미소장 |
| 208 | Gupta G, Borglum K, Chen H. Immunogenic cell death: A step ahead of autophagy in cancer therapy. J Cancer Immunol. 2021;3(1):47–59. | 미소장 |
| 209 | Chang X, Bian M, Liu L, Yang J, Yang Z, Wang Z, Lu Y, Liu W. Induction of immunogenic cell death by novel platinum-based anticancer agents. Pharmacol Res. 2023;187:Article 106556. | 미소장 |
| 210 | Zhang J, Sun X, Zhao X, Yang C, Shi M, Zhang B, Hu H, Qiao M, Chen D, Zhao X. Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy. Acta Pharm Sin B. 2022;12(9):3694–3709. | 미소장 |
| 211 | Del Prete A, Salvi V, Soriani A, Laffranchi M, Sozio F, Bosisio D, Sozzani S. Dendritic cell subsets in cancer immunity and tumor antigen sensing. Cell Mol Immunol. 2023;20(5):432–447. | 미소장 |
| 212 | Garg AD, Agostinis P. Cell death and immunity in cancer:From danger signals to mimicry of pathogen defense responses. Immunol Rev. 2017;280(1):126–148. | 미소장 |
| 213 | Palanivelu L, Liu C-H, Lin L-T. Immunogenic cell death:The cornerstone of oncolytic viro-immunotherapy. Front Immunol. 2022;13:1038226. | 미소장 |
| 214 | Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G, Galluzzi L. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 2020;11(11):1013. | 미소장 |
| 215 | Larson AC, Knoche SM, Brumfield GL, Doty KR, Gephart BD, Moore-Saufley PR, Solheim JC. Gemcitabine modulates HLA-I regulation to improve tumor antigen presentation by pancreatic cancer cells. Int J Mol Sci. 2024;25(6):3211. | 미소장 |
| 216 | Zhu R, Su L, Dai J, Li Z-W, Bai S, Li Q, Chen X, Song J, Yang H. Biologically responsive plasmonic assemblies for second near-infrared window photoacoustic imagingguided concurrent chemo-immunotherapy. ACS Nano. 2020;14(4):3991–4006. | 미소장 |
| 217 | Zhai T, Zhong W, Gao Y, Zhou H, Zhou Z, Liu X, Yang S, Yang H. Tumor microenvironment-activated nanoparticles loaded with an iron-carbonyl complex for chemodynamic immunotherapy of lung metastasis of melanoma in vivo. ACS Appl Mater Interfaces. 2021;13(33):39100–39111. | 미소장 |
| 218 | Zhang F, Chen F, Yang C, Wang L, Hu H, Li X, Zheng X, Wang Z, Chang Z, Li T, et al. Coordination and redox dualresponsive mesoporous organosilica nanoparticles amplify immunogenic cell death for cancer chemoimmunotherapy. Small. 2021;17(26):e2100006. | 미소장 |
| 219 | Shao D, Zhang F, Chen F, Zheng X, Hu H, Yang C, Tu Z, Wang Z, Chang Z, Lu J, et al. Biomimetic diselenide-bridged mesoporous organosilica nanoparticles as an X-rayresponsive biodegradable carrier for chemo-immunotherapy. Adv Mater. 2020;32(50):e2004385. | 미소장 |
| 220 | Sun K, Hu J, Meng X, Lei Y, Zhang X, Lu Z, Zhang L, Wang Z. Reinforcing the induction of immunogenic cell death via artificial engineered cascade bioreactorenhanced chemo-immunotherapy for optimizing cancer immunotherapy. Small. 2021;17(37):2101897. | 미소장 |
| 221 | Lhuillier C, Rudqvist N-P, Elemento O, Formenti SC, Demaria S. Radiation therapy and anti-tumor immunity:Exposing immunogenic mutations to the immune system. Genome Med. 2019;11(1):40. | 미소장 |
| 222 | Asadzadeh Z, Safarzadeh E, Safaei S, Baradaran A, Mohammadi A, Hajiasgharzadeh K, Derakhshani A, Argentiero A, Silvestris N, Baradaran B. Current approaches for combination therapy of cancer: The role of immunogenic cell death. Cancers. 2020;12(4):1047. | 미소장 |
| 223 | Schildkopf P, Frey B, Mantel F, Ott OJ, Weiss E-M, Sieber R, Janko C, Sauer R, Fietkau R, Gaipl US. Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells. Biochem Biophys Res Commun. 2010;391(1):1014–1020. | 미소장 |
| 224 | Yang W, Xiu Z, He Y, Huang W, Li Y, Sun T. Bip inhibition in glioma stem cells promotes radiation-induced immunogenic cell death. Cell Death Dis. 2020;11(9):786. | 미소장 |
| 225 | Xi Y, Chen L, Tang J, Yu B, Shen W, Niu X. Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy. Immunol Rev. 2024;321(1):94–114. | 미소장 |
| 226 | Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med. 2006;203(5):1259–1271. | 미소장 |
| 227 | Storozynsky Q, Hitt MM. The impact of radiation-induced DNA damage on cGAS-STING-mediated immune responses to cancer. Int J Mol Sci. 2020;21(22):8877. | 미소장 |
| 228 | Cadet J, Wagner JR. DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. Cold Spring Harb Perspect Biol. 2013;5(2):a012559. | 미소장 |
| 229 | Chargari C, Rassy E, Helissey C, Achkar S, Francois S, Deutsch E, Chapter Three—Impact of radiation therapy on healthy tissues. Int Rev Cell Mol Biol. 2023;376:69–98. | 미소장 |
| 230 | Bergerud KMB, Berkseth M, Pardoll DM, Ganguly S, Kleinberg LR, Lawrence J, Odde DJ, Largaespada DA, Terezakis SA, Sloan L. Radiation therapy and myeloid-derived suppressor cells: Breaking down their cancerous partnership. Int J Radiat Oncol Biol Phys. 2024;119(1):42–55. | 미소장 |
| 231 | Ostrand-Rosenberg S, Horn LA, Ciavattone NG. Radiotherapy both promotes and inhibits myeloid-derived suppressor cell function: Novel strategies for preventing the tumor-protective effects of radiotherapy. Front Oncol. 2019;9:215. | 미소장 |
| 232 | Pei P, Shen W, Zhou H, Sun Y, Zhong J, Liu T, Yang K. Radionuclide labeled gold nanoclusters boost effective antitumor immunity for augmented radio-immunotherapy of cancer. Nano Today. 2021;38:Article 101144. | 미소장 |
| 233 | Kim DH, Choi B, Choi H, Yu B. Synergistic local combination of radiation and anti-programmed death ligand 1 immunotherapy using radiation-responsive splintery metallic nanocarriers. ACS Nano. 2020;14(10):13115–13126. | 미소장 |
| 234 | Zhen W, Weichselbaum RR, Lin W. Nanoparticle-mediated radiotherapy remodels the tumor microenvironment to enhance antitumor efficacy. Adv Mater. 2023;35(21):e2206370. | 미소장 |
| 235 | Overchuk M, Weersink RA, Wilson BC, Zheng G. Photodynamic and photothermal therapies: Synergy opportunities for nanomedicine. ACS Nano. 2023;17(9):7979–8003. | 미소장 |
| 236 | Cheng X, Wei Y, Jiang X, Wang C, Liu M, Yan J, Zhang L, Zhou Y. Insight into the prospects for tumor therapy based on photodynamic immunotherapy. Pharmaceuticals. 2022;15(11):1359. | 미소장 |
| 237 | Liu Z, Xie Z, Li W, Wu X, Jiang X, Li G, Cao L, Zhang D, Wang Q, Xue P, et al. Photodynamic immunotherapy of cancers based on nanotechnology: Recent advances and future challenges. J. Nanobiotechnology. 2021;19(1):160. | 미소장 |
| 238 | Li J, Wang J, Zhang J, Han T, Hu X, Lee MMS, Wang D, Tang BZ. A facile strategy of boosting photothermal conversion efficiency through state transformation for cancer therapy. Adv Mater. 2021;33(51):e2105999. | 미소장 |
| 239 | Wang P, Chen B, Zhan Y, Wang L, Luo J, Xu J, Zhan L, Li Z, Liu Y, Wei J. Enhancing the efficiency of mild-temperature photothermal therapy for cancer assisting with various strategies. Pharmaceutics. 2022;14(11):2279. | 미소장 |
| 240 | Chen J, Ma Y, Du W, Dai T, Wang Y, Jiang W, Wan Y, Wang Y, Liang G, Wang G. Furin-instructed intracellular gold nanoparticle aggregation for tumor photothermal therapy. Adv Funct Mater. 2020;30(50):2001566. | 미소장 |
| 241 | Lei W, Sun C, Jiang T, Gao Y, Yang Y, Zhao Q, Wang S. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemophotothermal therapy. Mater Sci Eng C Mater Biol Appl. 2019;105:Article 110103. | 미소장 |
| 242 | Xu Z, Wang T, Liu J. Recent development of polydopamine anti-bacterial nanomaterials. Int J Mol Sci. 2022;23(13):7278. | 미소장 |
| 243 | Maharjan PS, Bhattarai HK. Singlet oxygen, photodynamic therapy, and mechanisms of cancer cell death. J Oncol. 2022;2022:7211485. | 미소장 |
| 244 | Gulati LK, Gulati GK, Kumar S. Photochromic materials as a photosensitizer in reversible reactive singlet oxygen generation. Dyes Pigm. 2022;199:Article 110104. | 미소장 |
| 245 | Thakur NS, Patel G, Kushwah V, Jain S, Banerjee UC. Facile development of biodegradable polymer-based nanotheranostics: Hydrophobic photosensitizers delivery, fluorescence imaging and photodynamic therapy. J Photochem Photobiol B. 2019;193:39–50. | 미소장 |
| 246 | Camerin M, Moreno M, Marín MJ, Schofield CL, Chambrier I, Cook MJ, Coppellotti O, Jori G, Russell DA. Delivery of a hydrophobic phthalocyanine photosensitizer using PEGylated gold nanoparticle conjugates for the in vivo photodynamic therapy of amelanotic melanoma. Photochem Photobiol Sci. 2016;15:618–625. | 미소장 |
| 247 | Liu Y, Ma K, Jiao T, Xing R, Shen G, Yan X. Water-insoluble photosensitizer nanocolloids stabilized by supramolecular interfacial assembly towards photodynamic therapy. Sci Rep. 2017;7:42978. | 미소장 |
| 248 | Huang H, Feng W, Chen Y, Shi J. Inorganic nanoparticles in clinical trials and translations. Nano Today. 2020;35:Article 100972. | 미소장 |
| 249 | Twomey JD, Zhang B. Cancer immunotherapy update: FDAapproved checkpoint inhibitors and companion diagnostics. AAPS J. 2021;23(2):39. | 미소장 |
| 250 | Hu Y, Welsh J, Paris S, Barsoumian H, Abana C, Gandhi S, Nguyen Q, Cortez M. 200 NBTXR3 nanoparticle with immunoradiation improves survival and generates long-term anti-tumor memory in an anti-PD1 resistant murine lung cancer model. J Immunother Cancer. 2020;8. | 미소장 |
| 251 | Shen C, Frakes JM, Niu J, Rosenberg A, Weiss J, Caudell JJ, Jameson KL, Said P, Seiwert TY. A phase I trial evaluating NBTXR3 activated by radiotherapy in combination with nivolumab or pembrolizumab in patients with advanced cancers. J Clin Oncol. 2021;39:2590. | 미소장 |
| 252 | He X, Xu C. Immune checkpoint signaling and cancer immunotherapy. Cell Res. 2020;30(8):660–669. | 미소장 |
| 253 | Wang L, Geng H, Liu Y, Liu L, Chen Y, Wu F, Liu Z, Ling S, Wang Y, Zhou L. Hot and cold tumors:Immunological features and the therapeutic strategies. MedComm. 2023;4(5):Article e343. | 미소장 |
| 254 | Liu Y-T, Sun Z-J. Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics. 2021;11(11):5365–5386. | 미소장 |
| 255 | Cremolini C, Vitale E, Rastaldo R, Giachino C. Advanced nanotechnology for enhancing immune checkpoint blockade therapy. Nanomaterials. 2021;11(3):661. | 미소장 |
| 256 | Song W, Jia P, Zhang T, Dou K, Liu L, Ren Y, Liu F, Xue J, Hasanin MS, Qi H, et al. Cell membrane-camouflaged inorganic nanoparticles for cancer therapy. J Nanobiotechnology. 2022;20(1):289. | 미소장 |
| 257 | Vijayan V, Uthaman S, Park I-K. Cell membrane-camouflaged nanoparticles: A promising biomimetic strategy for cancer theragnostics. Polymers. 2018;10(9):983. | 미소장 |
| 258 | Shang L, Zhou X, Zhang J, Shi Y, Zhong L. Metal nanoparticles for photodynamic therapy: A potential treatment for breast cancer. Molecules. 2021;26(21):6532. | 미소장 |
| 259 | Farzam OR, Mehran N, Bilan F, Aghajani E, Dabbaghipour R, Shahgoli GA, Baradaran B. Nanoparticles for imaging-guided photothermal therapy of colorectal cancer. Heliyon. 2023;9(11):Article e21334. | 미소장 |
| 260 | Liao Z, Huang J, Lo P-C, Lovell JF, Jin H, Yang K. Selfadjuvanting cancer nanovaccines. J Nanobiotechnology. 2022;20(1):345. | 미소장 |
| 261 | Choi J, Kim SY. Photothermally enhanced photodynamic therapy based on glutathione-responsive pheophorbide a-conjugated gold nanorod formulations for cancer theranostic applications. J Ind Eng Chem. 2020;85:66–74. | 미소장 |
| 262 | Raggi F, Pelassa S, Pierobon D, Penco F, Gattorno M, Novelli F, Eva A, Varesio L, Giovarelli M, Bosco MC. Regulation of human macrophage M1-M2 polarization balance by hypoxia and the triggering receptor expressed on myeloid cells-1. Front Immunol. 2017;8:1097. | 미소장 |
| 263 | Liu J, Li G, Guo H, Ni C, Gao Y, Cao X, Xia J, Shi X, Guo R. Dual-responsive core–shell tecto dendrimers enable efficient gene editing of cancer cells to boost immune checkpoint blockade therapy. ACS Appl Mater Interfaces. 2023;15(10):12809–12821. | 미소장 |
| 264 | Liu H, Han J, Lv Y, Zhao Z, Zheng S, Sun Y, Sun T. Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression. J Nanobiotechnology. 2023;21:208. | 미소장 |
| 265 | Kang Y, Yan J, Han X, Wang X, Wang Y, Song P, Su X, Rauf A, Jin X, Pu F, et al. Construction of hierarchically biomimetic iron oxide nanosystems for macrophage repolarization-promoted immune checkpoint blockade of cancer immunotherapy. ACS Appl Mater Interfaces. 2024;16(28):36131–36141. | 미소장 |
| 266 | Li J, Ren H, Sun Y, Liu G, Yang X, Qiu Q, Ding Y, Lovell JF, Zhang Y. Magnetic metal micelles for enhanced delivery of self-immolating CD8+ T-cell epitopes for cancer immunotherapy. Chem Mater. 2021;33(24):9780–9794. | 미소장 |
| 267 | Huang K-W, Hsu F-F, Qiu JT, Chern G-J, Lee Y-A, Chang C-C, Huang Y-T, Sung Y-C, Chiang C-C, Huang R-L, et al. Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Sci Adv. 2024;6(3):eaax5032. | 미소장 |
| 268 | Zhao Z, Dong S, Liu Y, Wang J, Ba L, Zhang C, Cao X, Wu C, Yang P. Tumor microenvironment-activable manganeseboosted catalytic immunotherapy combined with PD-1checkpoint blockade. ACS Nano. 2022;16(12):20400–20418. | 미소장 |
| 269 | Hou L, Tian C, Yan Y, Zhang L, Zhang H, Zhang Z. Manganese-based nanoactivator optimizes cancer immunotherapy via enhancing innate immunity. ACS Nano. 2020;14(4):3927–3940. | 미소장 |
| 270 | Zhang D, Wu T, Qin X, Qiao Q, Shang L, Song Q, Yang C, Zhang Z. Intracellularly generated immunological gold nanoparticles for combinatorial photothermal therapy and immunotherapy against tumor. Nano Lett. 2019;19(9):6635–6646. | 미소장 |
| 271 | Choi J, Shim MK, Yang S, Hwang HS, Cho H, Kim J, Yun WS, Moon Y, Kim J, Yoon HY, et al. Visible-light-triggered prodrug nanoparticles combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy. ACS Nano. 2021;15:12086–12098. | 미소장 |
| 272 | Cao F, Yan M, Liu Y, Liu L, Ma G. Photothermally controlled MHC class I restricted CD8+ T-cell responses elicited by hyaluronic acid decorated gold nanoparticles as a vaccine for cancer immunotherapy. Adv Healthc Mater. 2018;7(10):1701439. | 미소장 |
| 273 | Shinchi H, Yamaguchi T, Moroishi T, Yuki M, Wakao M, Cottam HB, Hayashi T, Carson DA, Suda Y. Gold nanoparticles coimmobilized with small molecule toll-like receptor 7 ligand and α-mannose as adjuvants. Bioconjug Chem. 2019;30(11):2811–2821. | 미소장 |
| 274 | Hou W, Wei P, Kong L, Guo R, Wang S, Shi X. Partially PEGylated dendrimer-entrapped gold nanoparticles: A promising nanoplatform for highly efficient DNA and siRNA delivery. J Mater Chem B. 2016;4(17):2933–2943. | 미소장 |
| 275 | Feng Q, Xiao K. Nanoparticle-mediated delivery of STAT3inhibitors in the treatment of lung cancer. Pharmaceutics. 2022;14(12):2787. | 미소장 |
| 276 | Ruan S, Xie R, Qin L, Yu M, Xiao W, Hu C, Yu W, Qian Z, Ouyang L, He Q, et al. Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment. Nano Lett. 2019;19(11):8318–8332. | 미소장 |
| 277 | Cha BG, Jeong JH, Kim J. Extra-large pore mesoporous silica nanoparticles enabling co-delivery of high amounts of protein antigen and toll-like receptor 9 agonist for enhanced cancer vaccine efficacy. ACS Cent Sci. 2018;4(4):484–492. | 미소장 |
| 278 | Wang X, Li X, Ito A, Sogo Y, Watanabe Y, Hashimoto K, Yamazaki A, Ohno T, Tsuji NM. Synergistic effects of stellated fibrous mesoporous silica and synthetic dsRNA analogues for cancer immunotherapy. Chem Commun. 2018;54(9):1057–1060. | 미소장 |
| 279 | Kim J, Li WA, Choi Y, Lewin SA, Verbeke CS, Dranoff G, Mooney DJ. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat Biotechnol. 2015;33(1):64–72. | 미소장 |
| 280 | Stater EP, Morcos G, Isaac E, Ogirala A, Hsu H-T, Longo VA, Grimm J. Translatable drug-loaded iron oxide nanophore sensitizes murine melanoma tumors to monoclonal antibody immunotherapy. ACS Nano. 2023;17(7):6178–6192. | 미소장 |
| 281 | Xu L, Xiang J, Liu Y, Xu J, Luo Y, Feng L, Liu Z, Peng R. Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity. Nanoscale. 2016;8(6):3785–3795. | 미소장 |
| 282 | Xu C, Hong H, Lee Y, Park KS, Sun M, Wang T, Aikins ME, Xu Y, Moon JJ. Efficient lymph node-targeted delivery of personalized cancer vaccines with reactive oxygen speciesinducing reduced graphene oxide nanosheets. ACS Nano. 2020;14(10):13268–13278. | 미소장 |
| 283 | Qiang N, Wei L, Tao Y, Jin W, Bin Y, DingHua Z. Construction of Durvalumab/carbon nanotube/PEI/aptamersiRNA chimera for the immunotherapy of hepatocellular carcinoma. Biomed Mater. 2022;17(2):025015. | 미소장 |
| 284 | Li D, Ahmed M, Khan A, Xu L, Walters AA, Ballesteros B, Al-Jamal KT. Tailoring the architecture of cationic polymer brush-modified carbon nanotubes for efficient siRNA delivery in cancer immunotherapy. ACS Appl Mater Interfaces. 2021;13(26):30284–30294. | 미소장 |
| 285 | Liu H, Xie Z, Zheng M. Carbon dots and tumor antigen conjugates as nanovaccines for elevated cancer immunotherapy. Small. 2023;19(31):2206683. | 미소장 |
| 286 | Chen P, He X, Hu Y, Tian X-L, Yu X-Q, Zhang J. Spleentargeted mRNA delivery by amphiphilic carbon dots for tumor immunotherapy. ACS Appl Mater Interfaces. 2023;15(16):19937–19950. | 미소장 |
| 287 | Su W, Tan M, Wang Z, Zhang J, Huang W, Song H, Wang X, Ran H, Gao Y, Nie G, et al. Targeted degradation of PD-L1and activation of the STING pathway by carbon-dot-based PROTACs for cancer immunotherapy. Angew Chem Int Ed Engl. 2023;62(11):Article e202218128. | 미소장 |
| 288 | Zhao J, Chen G, Pang X, Zhang P, Hou X, Chen P, Xie Y-W, He C-Y, Wang Z, Chen Z-Y. Calcium phosphate nanoneedle based gene delivery system for cancer genetic immunotherapy. Biomaterials. 2020;250:Article 120072. | 미소장 |
| 289 | Anoop M, Nambiar AR, Nair SV, Koyakutty M, Ashokan A. Zoledronic acid conjugated calcium phosphate nanoparticles for applications in cancer immunotherapy. Mater Today Commun. 2022;30:Article 103065. | 미소장 |
| 290 | Zhou M, Liang S, Liu D, Ma K, Yun K, Yao J, Peng Y, Hai L, Zhang Q, Wang Z. Manganese-enriched zinc peroxide functional nanoparticles for potentiating cancer immunotherapy. Nano Lett. 2023;23(22):10350–10359. | 미소장 |
| 291 | Luo G, Li X, Lin J, Ge G, Fang J, Song W, Xiao GG, Zhang B, Peng X, Duo Y, et al. Multifunctional calcium–manganese nanomodulator provides antitumor treatment and improved immunotherapy via reprogramming of the tumor microenvironment. ACS Nano. 2023;17(16):15449–15465. | 미소장 |
| 292 | Mu Q, Lin G, Jeon M, Wang H, Chang F-C, Revia RA, Yu J, Zhang M. Iron oxide nanoparticle targeted chemoimmunotherapy for triple negative breast cancer. Mater Today. 2021;50:149–169. | 미소장 |
| 293 | Hou L, Chen D, Wang R, Wang R, Zhang H, Zhang Z, Nie Z, Lu S. Transformable honeycomb-like nanoassemblies of carbon dots for regulated multisite delivery and enhanced antitumor chemoimmunotherapy. Angew Chem Int Ed Engl. 2021;60(12):6581–6592. | 미소장 |
| 294 | Bao Y, Li G, Li S, Zhang H, Wu X, Yan R, Wang Z, Guo C, Jin Y. Multifunctional tumor-targeting carbon dots for tumor microenvironment activated ferroptosis and immunotherapy in cancer treatment. ACS Appl Mater Interfaces. 2023;15(49):56834–56845. | 미소장 |
| 295 | Kumar S, Mongia A, Gulati S, Singh P, Diwan A, Shukla S. Emerging theranostic gold nanostructures to combat cancer: Novel probes for combinatorial immunotherapy and photothermal therapy. Cancer Treat Res Commun. 2020;25:Article 100258. | 미소장 |
| 296 | Wang M, Li Y, Wang M, Liu K, Hoover AR, Li M, Towner RA, Mukherjee P, Zhou F, Qu J, et al. Synergistic interventional photothermal therapy and immunotherapy using an iron oxide nanoplatform for the treatment of pancreatic cancer. Acta Biomater. 2022;138:453–462. | 미소장 |
| 297 | Gao Y, Chen X, Wang B, Wang S, Wang J, Ren L, Jin W, Han H, Wang L. Engineering platelets with PDL1 antibodies and iron oxide nanoparticles for postsurgical cancer immunotherapy. ACS Appl Bio Mater. 2023;6(1):257–266. | 미소장 |
| 298 | Yuan Z, He H, Zou J, Wang H, Chen Y, Chen Y, Lan M, Zhao Y, Gao F. Polydopamine-coated ferric oxide nanoparticles for R848 delivery for photothermal immunotherapy in breast cancer. Int J Pharm. 2023;644:Article 123249. | 미소장 |
| 299 | Tao Y, Ju E, Ren J, Qu X. Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer therapy. Biomaterials. 2014;35(37):9963–9971. | 미소장 |
| 300 | Zhou F, Wang M, Luo T, Qu J, Chen WR. Photoactivated chemo-immunotherapy for metastatic cancer using a synergistic graphene nanosystem. Biomaterials. 2021;265:Article 120421. | 미소장 |
| 301 | Liu S, Zhang M, Yu H, Sun X, Li Q, Yang M, Qiu X, Su H, Gong A, Du F. Immunoinducible carbon dot-incorporated hydrogels as a photothermal-derived antigen depot to trigger a robust antitumor immune response. ACS Appl Mater Interfaces. 2023;15(6):7700–7712. | 미소장 |
| 302 | Li Z, Chu Z, Yang J, Qian H, Xu J, Chen B, Tian T, Chen H, Xu Y, Wang F. Immunogenic cell death augmented by manganese zinc sulfide nanoparticles for metastatic melanoma immunotherapy. ACS Nano. 2022;16(9):15471–15483. | 미소장 |
| 303 | Chen Y, Ma H, Wang W, Zhang M. A size-tunable nanoplatform: Enhanced MMP2-activated chemophotodynamic immunotherapy based on biodegradable mesoporous silica nanoparticles. Biomater Sci. 2021;9(3):917–929. | 미소장 |
| 304 | Wu X, Cheng Y, Zheng R, Xu K, Yan J, Song P, Wang Y, Rauf A, Pan Y, Zhang H. Immunomodulation of tumor microenvironment by arginine-loaded iron oxide nanoparticles for gaseous immunotherapy. ACS Appl Mater Interfaces. 2021;13(17):19825–19835. | 미소장 |
MARC 보기
오류 데이터 정정요청
*표시는 필수 입력사항입니다.
알림톡 발송
| 전화번호 |
|---|
개인정보 수정 바로가기
연속간행물 권호 선택
우편복사 안내
- ◾ 도서관을 방문하지 못할 경우 인터넷, 팩스 등으로 자료 복사를 신청하고, 복사물을 우편·팩스 등으로 제공받는 서비스
- ◾ 대상자료: 일반도서, 연속간행물 및 학위논문
- ※ 고서, 고잡지, 훼손될 우려가 있는 자료, 마이크로폼 자료 및 신문 등 제외
- ◾ 신청 책수: 1인 5책 이하(1일 기준)
- ◾ 신청 절차: 자료 검색 → 우편복사 목록담기 → 복사 범위 입력 → 우편복사 주문서 입력 → 접수 및 확인
- ※ 저작권법에 의거하여 부분 복사(전체 페이지 수의 1/3 범위 이내)만 가능
- ◾ 복사 범위 입력 예시: (연속 페이지) 1-30, (부분 페이지) 25, 30-40
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내(서울관)
도서위치안내: / 서가번호:
0
확인
우편복사 목록담기를 완료하였습니다.
내서재에 담기
새로운 서재
*표시는 필수 입력사항입니다.
저장
저장 되었습니다.